AN UNBIASED VIEW OF LINK ALTERNATIF MBL77

Not all sufferers with CLL need therapy. Despite all modern improvements, the iwCLL however recommends watchful observation for patients with asymptomatic illness.86 This suggestion relies on a minimum of two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Ea